The etiology of cardiac hypertrophy in infants
Abstract This study aimed to describe the variety of etiologies currently identified in infants with cardiac hypertrophy (CH) and investigate whether there is a relation with hyperinsulinism, echocardiographic characteristics and prognosis. This retrospective cohort study included infants born betwe...
Saved in:
Main Authors: | Raymond Stegeman, Nina D. Paauw, Rosalie de Graaf, Rosa L. E. van Loon, Jacqueline U. M. Termote, Johannes M. P. J. Breur |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/8a59adf57ea541cf85c61b74b3c51427 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Wild type transthyretin cardiac amiloidozis as a rare and overlooked underlying etiology in a patient with heart failure with preserved ejection fraction and left ventricular hypertrophy
by: Selda Murat, et al.
Published: (2021) -
Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
by: Ke-Qiong Deng, et al.
Published: (2016) -
Cardiac-specific microRNA-125b deficiency induces perinatal death and cardiac hypertrophy
by: Chen-Yun Chen, et al.
Published: (2021) -
AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation
by: Roselle Gélinas, et al.
Published: (2018) -
Genetic contributions to the expression of acquired causes of cardiac hypertrophy in non-ischemic sudden cardiac death victims
by: Lauri Holmström, et al.
Published: (2021)